V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013937 | 270019223 | 1.62 | 77.6 | Palliative (P) | 2013-08-29 | 2013-09-01 | CHLVPP | N | N | 270016149 | CHLVPP |
| 270013938 | 270016957 | 1.82 | 69 | Palliative (P) | 2016-01-12 | 2016-01-27 | Trifluridine + Tipiracil | N | N | 270016154 | TRIFLURIDINE + TIPIRACIL |
| 270013939 | 270018404 | 1.78 | 70.6 | Neo-adjuvant (N) | 2014-11-29 | 2014-12-08 | Bevacizumab + Oxaliplatin +MdG | N | Y | 270016155 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013940 | 270009509 | 1.64 | 69 | Curative (C) | 2014-04-20 | 2014-04-20 | Cetuximab + Radiotherapy Maint | N | null | 270016159 | CETUXIMAB + RT |
| 270013941 | 270016958 | 1.59 | 90 | Curative (C) | 2015-12-30 | 2016-01-05 | CISPLATIN + FLUOROURACIL | 02 | N | 270016176 | CISPLATIN + FLUOROURACIL |
| 270013942 | 270009510 | 1.6 | 68.3 | Adjuvant (A) | 2017-03-28 | 2017-04-05 | Fluorouracil + Folinic Acid Weekly | 2 | Y | 270016180 | FLUOROURACIL |
| 270013943 | 270009511 | 1.64 | 54 | Curative (C) | 2017-01-21 | 2017-01-21 | DHAP | 02 | null | 270016184 | DHAP |
| 270013944 | 270009511 | null | 28.3 | Curative (C) | 2015-08-25 | 2015-08-27 | Cetuximab + Radiotherapy Load | N | null | 270016184 | CETUXIMAB + RT |
| 270013946 | 270009515 | 1.61 | 64.9 | Palliative (P) | 2013-05-07 | 2013-05-07 | Cetuximab + Radiotherapy Maint | 02 | N | 270016196 | CETUXIMAB + RT |
| 270013947 | 270009515 | 1.8 | 98.1 | Palliative (P) | 2015-12-01 | 2015-12-04 | Fluouracil continuous infusion | N | N | 270016196 | FLUOROURACIL |
| 270013948 | 270009515 | 1.67 | 85.1 | Adjuvant (A) | 2018-01-26 | 2018-10-15 | Capecitabine (21 day) + Irinotecan | null | N | 270016196 | CAPECITABINE + IRINOTECAN |
| 270013949 | 270009516 | 1.71 | 72.4 | Neo-adjuvant (N) | 2014-12-28 | 2015-01-05 | Bevacizumab + Oxaliplatin +MdG | N | Y | 270016209 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013950 | 270009519 | 1.63 | null | Palliative (P) | 2016-02-09 | 2016-02-14 | Trifluridine + Tipiracil | N | N | 270016216 | TRIFLURIDINE + TIPIRACIL |
| 270013951 | 270009520 | 1.71 | null | Neo-adjuvant (N) | 2016-06-28 | 2016-07-11 | CAPECITABINE + RT | 2 | N | 270016217 | CAPECITABINE + RT |
| 270013952 | 270009521 | 1.65 | 61.1 | Neo-adjuvant (N) | 2016-01-01 | 2016-01-29 | Capecitabine 35days + RT | 99 | null | 270016217 | CAPECITABINE + RT |
| 270013953 | 270016962 | 1.76 | 62 | Palliative (P) | 2015-10-01 | 2016-02-18 | Trifluridine + Tipiracil | null | Y | 270016222 | TRIFLURIDINE + TIPIRACIL |
| 270013954 | 270009524 | 1.73 | 64.9 | Neo-adjuvant (N) | 2015-01-12 | 2015-01-15 | Bevacizumab + Oxaliplatin +MdG | N | Y | 270016227 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013955 | 270009526 | 1.6 | 98 | null | 2016-03-22 | 2016-03-23 | Cetuximab + Radiotherapy Maint | Y | N | 270016228 | CETUXIMAB + RT |
| 270013956 | 270009527 | 1.71 | 74 | Curative (C) | 2018-01-24 | 2018-02-20 | CHOP R - 21 days | 02 | N | 270016230 | CHOP R |
| 270013957 | 270014457 | null | 66 | Not known (9) | 2018-12-20 | 2018-12-20 | Fluorouracil + Folinic Acid Weekly | 02 | N | 270016233 | FLUOROURACIL |
| 270013958 | 270009530 | 1.64 | 73.6 | Disease modification (D) | 2014-07-20 | 2015-01-29 | CHOP R | N | Y | 270016236 | CHOP R |
| 270013959 | 270009531 | 1.62 | 56.3 | Curative (C) | 2017-11-27 | 2017-12-16 | Cetuximab + Radiotherapy Maint | 99 | null | 270016237 | CETUXIMAB + RT |
| 270013960 | 270009532 | 1.65 | null | Palliative (P) | 2014-12-11 | 2014-12-12 | Cisplatin +Fluorouracil (3 wk) | N | N | 270016243 | CISPLATIN + FLUOROURACIL |
| 270013961 | 270014458 | 1.9 | 64.9 | Curative (C) | 2015-09-08 | 2015-10-25 | Capecitabine 35days + RT | null | null | 270016243 | CAPECITABINE + RT |
| 270013962 | 270009534 | 1.73 | 40.1 | Palliative (P) | 2017-10-15 | 2018-04-07 | DHAP | N | N | 270016248 | DHAP |
| 270013963 | 270009535 | 1.78 | 65 | Palliative (P) | 2015-08-10 | 2015-08-27 | Cetuximab + Radiotherapy Maint | 02 | N | 270016249 | CETUXIMAB + RT |
| 270013964 | 270009536 | 1.66 | 70.4 | Curative (C) | 2018-10-20 | 2018-10-21 | DHAP | N | Y | 270016250 | DHAP |
| 270013965 | 270009540 | 1.62 | 70 | Curative (C) | 2017-11-27 | 2018-01-08 | CHLVPP | N | N | 270016250 | CHLVPP |
| 270013966 | 270019225 | 1.79 | 92 | Adjuvant (A) | null | 2016-05-08 | CHOP R - 21 days | 2 | N | 270016266 | CHOP R |
| 270013967 | 270009543 | null | 71.7 | Curative (C) | 2015-09-12 | 2015-09-25 | Capecitabine 35days + RT | 2 | N | 270016267 | CAPECITABINE + RT |
| 270013968 | 270009544 | 1.58 | 48.1 | Neo-adjuvant (N) | 2014-05-19 | 2015-06-03 | Capecitabine (21 day) + Irinotecan | 2 | Y | 270016268 | CAPECITABINE + IRINOTECAN |
| 270013969 | 270014463 | 1.73 | 99 | Curative (C) | null | 2013-08-01 | null | N | Y | 270016270 | NOT MATCHED |
| 270013970 | 270009548 | 1.77 | 78.9 | Palliative (P) | null | 2014-03-20 | CISPLATIN + FLUOROURACIL | 2 | N | 270016272 | CISPLATIN + FLUOROURACIL |
| 270013973 | 270009551 | 1.8 | 112 | Curative (C) | 2016-08-23 | 2016-09-07 | Trifluridine + Tipiracil | 02 | Y | 270016280 | TRIFLURIDINE + TIPIRACIL |
| 270013974 | 270014466 | 1.66 | 94.6 | Adjuvant (A) | 2017-11-18 | 2017-12-05 | Fluorouricil + Folonic Acid (MdG) | 02 | null | 270016282 | FLUOROURACIL |
| 270013975 | 270016967 | 1.62 | 73 | Palliative (P) | 2016-11-26 | 2016-11-26 | Cisplatin +Fluorouracil (2 wk) | N | N | 270016283 | CISPLATIN + FLUOROURACIL |
| 270013976 | 270016967 | 1.9 | 57.5 | Neo-adjuvant (N) | 2013-10-20 | 2013-11-08 | Capecitabine 35days + RT | N | N | 270016283 | CAPECITABINE + RT |
| 270013977 | 270009552 | 1.73 | 72 | Palliative (P) | 2014-05-24 | 2014-06-06 | CAPECITABINE + IRINOTECAN | N | N | 270016291 | CAPECITABINE + IRINOTECAN |
| 270013978 | 270009554 | 1.63 | 88.2 | Palliative (P) | 2014-08-26 | 2014-08-26 | Capecitabine (14 day) + Irinotecan | N | N | 270016297 | CAPECITABINE + IRINOTECAN |
| 270013979 | 270009557 | 1.49 | 48.6 | Neo-adjuvant (N) | 2014-02-13 | 2014-03-14 | CISPLATIN + FLUOROURACIL | N | Y | 270016298 | CISPLATIN + FLUOROURACIL |
| 270013980 | 270009558 | 1.58 | 64 | Disease modification (D) | 2015-09-20 | 2015-09-27 | CHLVPP | N | Y | 270016298 | CHLVPP |
| 270013981 | 270009559 | 1.61 | 68.2 | Neo-adjuvant (N) | null | 2014-11-20 | Bevacizumab + Oxaliplatin +MdG | 02 | Y | 270016305 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013982 | 270009561 | 1.74 | 60 | null | 2015-01-24 | 2015-02-15 | Shamash LBCMVD-56 | 02 | null | 270016309 | NOT MATCHED |
| 270013983 | 270009561 | null | null | Curative (C) | 2015-05-18 | 2018-03-08 | Cisplatin + Modified de Gramont | 02 | Y | 270016309 | CISPLATIN + FLUOROURACIL |
| 270013985 | 270009563 | 1.61 | 73.2 | Palliative (P) | 2015-02-27 | 2015-03-12 | Capecitabine (21 day) + Irinotecan | 02 | N | 270016322 | CAPECITABINE + IRINOTECAN |
| 270013986 | 270009564 | 1.67 | 67.8 | Curative (C) | 2018-06-27 | 2018-06-28 | DHAP | 2 | N | 270016323 | DHAP |
| 270013987 | 270019685 | 1.79 | 76 | Adjuvant (A) | 2014-10-22 | 2014-10-23 | Fluorouricil + Folonic Acid (MdG) | N | N | 270016327 | FLUOROURACIL |
| 270013988 | 270009565 | 1.98 | 66.9 | Adjuvant (A) | 2017-08-23 | 2017-11-07 | CHLVPP | 02 | N | 270016329 | CHLVPP |
| 270013989 | 270009566 | null | null | Curative (C) | 2018-07-08 | 2018-07-22 | DHAP | N | N | 270016336 | DHAP |
| 270013990 | 270009567 | 1.52 | 61.1 | Palliative (P) | null | 2018-03-18 | Capecitabine (21 day) + Irinotecan | N | N | 270016336 | CAPECITABINE + IRINOTECAN |